Non-Cutaneous Melanoma — Trials

Non-Cutaneous Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

312 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 87
Recruiting: 44
Ph III recruiting: 6
Growth YoY: —
Industry share: 28%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 1–26 of 26 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04511013	A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases	recruiting	Phase 2	112	SWOG Cancer Research NetworkNETWORK	1	Sep 15, 2026	clinicaltrials
NCT05546827	Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma	recruiting	Phase 2	40	M.D. Anderson Cancer CenterOTHER	1	Sep 10, 2026	clinicaltrials